Your browser doesn't support javascript.
loading
Frecuencia del polimorfismo PD-1.3 del gen del receptor de muerte celular programada 1 (PD-1) y su asociación con diabetes tipo 1 / Frequency of polymorphism PD-1.3 of programmed cell death 1 (PD-1) and their association with type 1 diabetes
Vásquez O., Karla; Soto S., Johana; Pizarro A., Carolina; Salas P., Francisca; Pérez B., Francisco.
  • Vásquez O., Karla; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Laboratorio de Genómica Nutricional. CL
  • Soto S., Johana; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Laboratorio de Genómica Nutricional. CL
  • Pizarro A., Carolina; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Laboratorio de Genómica Nutricional. CL
  • Salas P., Francisca; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Laboratorio de Genómica Nutricional. CL
  • Pérez B., Francisco; Universidad de Chile. Facultad de Medicina. Departamento de Nutrición. Laboratorio de Genómica Nutricional. CL
Rev. chil. endocrinol. diabetes ; 6(2): 55-58, abr. 2013. tab
Article in Spanish | LILACS | ID: lil-726575
ABSTRACT

Background:

The programmed cell death 1 (PDCD-1) immune-receptor is a key element in the negative regulation of peripheral tolerance in T cells. The gene has several polymorphisms and can be associated with susceptibility to autoimmune diseases.

Aim:

To analyze the frequency and distribution of PD-1.3 polymorphism of PDCD-1 gene and explore its possible contribution as a susceptibility gene for type 1 diabetes (T1D). Patients and

Methods:

We analyzed 248 cases with T1D with recent diagnosis and 160 control children under 15 years of Santiago. Genetic polymorphism in PD-1 gene variant for PD-1.3 (rs 11568821) was analyzed by polymerase chain reaction and restriction fragment length polymorphism. Comparison of genotype, allele frequency and consistency with respect to Hardy-Weinberg were analyzed using X2 tests and Fisher exact test.

Results:

There was a very low frequency of the genotype A/A, both in T1D patients and in controls (< 2 percent). The A/G genotype was more common in diabetic patients than in controls (41.6 and 18.8 percent respectively, p < 0.04). G/G genotype was more common in controls than in patients (79.4 and 56.8 percent respectively, p < 0.02). T1D patients carrying genotype G/G had a higher frequency of anti-GAD65 and anti-A-2 antibodies (81 and 67 percent respectively).

Conclusions:

The distribution of PD-1.3 genotype frequencies are similar to that reported elsewhere. Possibly, this genetic variant (rs 11568821) does not have an important marker role in Chilean T1D patients.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Polymorphism, Genetic / Diabetes Mellitus, Type 1 / Programmed Cell Death 1 Receptor Type of study: Risk factors Limits: Adolescent / Child / Humans Language: Spanish Journal: Rev. chil. endocrinol. diabetes Journal subject: Endocrinology Year: 2013 Type: Article / Project document Affiliation country: Chile Institution/Affiliation country: Universidad de Chile/CL

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Polymorphism, Genetic / Diabetes Mellitus, Type 1 / Programmed Cell Death 1 Receptor Type of study: Risk factors Limits: Adolescent / Child / Humans Language: Spanish Journal: Rev. chil. endocrinol. diabetes Journal subject: Endocrinology Year: 2013 Type: Article / Project document Affiliation country: Chile Institution/Affiliation country: Universidad de Chile/CL